Koçak-19 Inactive Adjuvant COVID-19 Vaccine
/ Kocak Farma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 05, 2021
Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial
(clinicaltrials.gov)
- P2b; N=200; Not yet recruiting; Sponsor: Health Institutes of Turkey
Clinical • New P2b trial • Infectious Disease • Novel Coronavirus Disease • IFNG • IL2 • IL4 • IL5 • IL6 • TNFA
April 08, 2021
Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo
(clinicaltrials.gov)
- P1; N=38; Recruiting; Sponsor: Kocak Farma
New P1 trial • Infectious Disease • Novel Coronavirus Disease • IL2 • IL6 • TNFA
1 to 2
Of
2
Go to page
1